Journal Home
Search for

Volume 20, Issue 4, Pages 366-368 (July 2009)


View previous. 10 of 29 View next.

High blood pressure response to stress ergometry could predict future hypertension

Raymond FarahaCorresponding Author Informationemail address, Revital Shurtz-Swirskib, Makhoul Nicolac

Received 16 April 2008; received in revised form 30 July 2008; accepted 24 September 2008. published online 13 November 2008.

Abstract 

Background

Previous studies have shown that exaggerated blood pressure (BP) during exercise is a valid risk predictor for future hypertension in most men and women, yet the use of ergometry as a means of early detection of incipient hypertension still requires confirmation.

Objectives

To assess the clinical utility of exercise BP measurement for the evaluation of risk for developing new-onset hypertension.

Methods

Thirty individuals with normal BP were enrolled in this study and were subsequently divided into two groups: 13 persons with in-exercise hypertension were compared with 17 matched persons who were normotensive during ergometry. Their blood pressure was monitored during follow-up of two years.

Results

More individuals in the exercise-hypertensive group developed hypertension after one or two years than those normotensive during the exercise (respectively, one year: 3 vs.0, p=0.03, two years: 10 vs. 1, p<0.0001). Both the systolic and diastolic BPs significantly differed between the two groups. Eighty four percent of those with exaggerated BP (≥210 mm Hg) during the treadmill exercise developed hypertension after 2 years. The sensitivity and specificity of in-exercise hypertension for predicting its 2 year occurrence were, respectively, 91% and 84%.

Conclusion

Even in the absence of hypertension, its development during stress ergometry could be considered a predictive marker for the future development of hypertension, and can be a potential tool for identifying normotensive individuals at high risk. These individuals should be followed up and their BP controlled for a long time.

a Department of Internal Medicine B, Ziv Medical Center, Safed, Israel

b Eliachar Research Laboratory, Western Galilee Hospital, 22100, Nahariya, Israel

c Intensive Care Medicine, Western Galilee Hospital, 22100, Nahariya, Israel

Corresponding Author InformationCorresponding author. Tel.: +972 4 6828946; fax: +972 4 6828116.

PII: S0953-6205(08)00278-1

doi:10.1016/j.ejim.2008.09.016


View previous. 10 of 29 View next.